![]() |
市場調查報告書
商品編碼
2034934
全球導管固定市場:市場規模、佔有率和趨勢分析(2026-2032 年)Catheter Securement Market Size, Share, & Trends Analysis | Global | 2026-2032 | Includes: Manufactured Catheter Securement and 2 Other Segments |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
全球導管固定市場報告(至2032年)
2025年全球導管固定市場規模為22億美元。預計該市場將以3.2%的複合年成長率成長,到2032年達到27億美元。
本報告涵蓋全球導管固定市場,包括膠帶和敷料、導管固定裝置(MCSD)和縫合線。
分析內容包括銷售量、平均售價(ASP)、市場規模、市場佔有率、成長趨勢、到 2032 年的市場預測以及到 2022 年的歷史數據。
市場成長主要受導管插入次數增加、高品質固定產品廣泛應用以及減少感染疾病和導管相關併發症因素驅動。然而,微創導管固定裝置的高昂價格和激烈的市場競爭預計將限制市場規模的進一步擴張。
市場概覽
全球導管固定市場包括用於穩定靜脈通路裝置並降低導管移位、脫落、感染和併發症風險的產品。
該市場涵蓋膠帶和敷料、縫合線以及導管固定裝置。這些產品廣泛應用於周邊和中心靜脈通路,包括周邊靜脈置入中心靜脈導管 (PIVC)、經周邊靜脈置入中心靜脈導管 (PICC)、中心靜脈導管 (CVC)、中線導管及其他類型的導管。
導管固定與導管插入次數有密切關係。由於許多住院患者需要靜脈通路,因此導管固定產品在醫療機構中被廣泛使用。
旨在增強固定效果的輔助技術正在推動市場逐步擴張。基於黏合劑的固定增強劑和易於拆卸的安全機制是超越傳統固定平台的創新典範。這些技術旨在減少導管失效,提高病人安全,並增強中心靜脈和周邊靜脈通路環境中固定系統的提案。
市場促進因素
導尿管插入次數增加
導管插入次數的增加是導管固定市場的主要促進因素。銷售額與醫院和其他醫療機構進行的導管插入次數密切相關。
據估計,約90%的住院患者需要接受靜脈輸液。由於每次置入導管都需要某種形式的固定,因此導管固定裝置是常用的產品類型。
隨著全球人口老化,需要住院治療、輸液治療、血管通路置入以及慢性病治療的患者人數預計將會增加。這很可能在預測期內推動導管固定產品銷售的成長。
努力減少感染和導管相關併發症
減少感染疾病和導管相關併發症的努力也是關鍵的推動因素。醫療保險報銷方案的改變、醫療保健改善研究所 (IHI) 中心靜脈導管捆綁指南、液體護理研究所 (INS) 實踐標準以及醫院主導的安全措施,都在促進高品質產品的採用。
這些努力促使市場上推出了許多能夠減少感染和併發症的產品。例如,抗菌敷料和旨在增強導管穩定性的導管固定醫療設備。
「拯救500萬生命宣傳活動」和「PIV 5項權利」也支持改進導管插入固定方法。隨著醫療系統持續關注感染預防和併發症減少,預計市場將繼續採用價格更高的固定產品。
輔助固定技術的創新
輔助固定技術正在推動市場逐步成長。這些產品旨在增強固定效果,減少意外脫落,並提高導管穩定性。
例如,Adhezion Biomedical 的黏合劑型固定增強劑和 Lineus Medical 的防移位安全機制。這些產品體現了持續創新,超越了傳統的敷料、膠帶、縫線和標準導管固定裝置 (MCSD)。
這些技術的目標是減少導管故障並提高病人安全。隨著醫院越來越重視血管通路管理,這些輔助解決方案在中心靜脈和周邊靜脈通路方面都可能變得更加重要。
市場限制
MCSD 的價格相對較高
導管固定裝置的平均售價相對較高,這是限制其廣泛應用的主要因素。儘管微創導管固定裝置(MCSD)的發展勢頭強勁,但其高昂的成本阻礙了其普及。
這些產品通常與昂貴的中央靜脈導管聯合使用,但較少與周邊靜脈導管 (PIVC) 聯合使用。由於 PIVC 佔導管置入總量的絕大多數,MCSD 需要進一步拓展 PIVC 市場,以推動更強勁的成長。
要證明引入價格是導管本身兩倍以上的固定裝置的合理性並非易事。為了更廣泛地應用,必須降低價格,或必須進行詳細的成本分析,證明這些產品能夠顯著降低併發症、再次插入率和整體醫療保健成本,從而證明投資的合理性。
微軟SD面臨的競爭壓力
預計MCSD市場的競爭壓力將限制其價值成長。隨著更多公司進入該領域,主要競爭對手將努力捍衛其市場佔有率。
從長遠來看,這可能導致平均售價(ASP)下降。這種壓力在用於周邊靜脈置管(PIVC)的微創導管(MCSD)中尤其明顯,因為與經周邊靜脈置入中心靜脈導管(PICC)和中線導管相比,這些導管的置入包中通常不會包含固定式導管產品。
由於周邊靜脈留置針的固定裝置通常是根據個人需求選擇的,醫療專業人員可以選擇最適合自身需求的產品,而不是使用導管自帶的固定裝置。這種柔軟性可能會加劇市場競爭,並造成價格壓力。
成熟服飾類別的價格壓力
膠帶和敷料佔了導管固定產品需求的大部分,但這些類別已經成熟,競爭日益激烈。
標準敷料和膠帶應用廣泛,由於導尿管置入量大,許多醫護人員對價格非常敏感。即使是優質的抗菌敷料,也必須憑藉其降低感染的效果來證明其額外成本的合理性。
隨著採購部門持續關注成本控制,成熟敷料品類的價格壓力可能會限制市場價值成長。製造商將不得不依靠臨床差異化、抗菌性能和易用性來維持價格。
市場覆蓋範圍和數據範圍
目標市場及區隔
膠帶和敷料廣泛用於導管固定和保護穿刺部位。此類敷料包括標準敷料、靜脈輸液固定敷料、抗菌敷料以及用於中心靜脈和周邊靜脈通路的黏合劑產品。
縫合線用於固定某些類型的導管,特別是中心靜脈通路裝置。雖然縫合是一種成熟且常用的技術,但隨著現成固定方案的出現,市場正受到衝擊,這些方案規避了縫合相關的缺點。
導管固定裝置的設計旨在穩定導管,而無需完全依賴膠帶、敷料或縫線。雖然這些裝置可以減少導管移位、脫落及相關併發症,但其高昂的成本可能限制了它們的普及應用。這種趨勢在周邊靜脈導管(PIVC)的使用中尤其明顯。
每個細分市場都根據市場規模、市場佔有率、市場預測、市場成長率、銷售量和平均售價進行分析。
這種市場細分有助於製造商、投資者和策略團隊了解固定方法、導管類型、定價、感染預防和併發症減少如何塑造全球導管固定市場。
競爭分析
Solventum 於 2024 年 4 月從 3M 分拆出來,並在 2025 年成為導管固定領域的領先公司。該公司在敷料市場佔主導地位,尤其憑藉其 Tegaderm™ 系列產品。
諸如「Tegaderm™ CHG」抗菌敷料等產品定位較高價格,鞏固了Solventum的市場地位。該公司還提供「Medipore™」敷料,廣泛用於靜脈輸液固定和創傷護理。
此外,Solventum公司透過其PICC/CVC固定裝置及Tegaderm™系列產品,成功進軍導管固定裝置(MCSD)市場。因此,除了在敷料市場主導地位外,該公司在MCSD市場也獲得了雖不大但可觀的佔有率。
貝克頓·迪金森公司是成品導管固定裝置市場的主要競爭者。其於2006年收購的StatLock®系列產品至今仍在MCSD產品組合中佔主導地位。
憑藉在PICC、慢性中心靜脈導管和中線導管市場的強大地位,BD在導管固定裝置市場佔主導地位,無論是作為獨立產品還是在導管套件中。然而,由於其他公司的競爭以及一些競爭對手不願直接從BD採購,其市場佔有率略有下降。
史密斯-內普公司在敷料市場佔了相當大的佔有率。其IV3000®敷料用於靜脈穿刺部位護理,並提供多種尺寸,用於固定外周和中央靜脈導管。該公司還提供IV3000®單手敷料,方便使用;以及HYPAFIX®膠帶,用於固定周邊靜脈導管(PIVC)。
技術和臨床趨勢
抗菌敷料
隨著醫院越來越重視感染預防,抗菌敷料的重要性日益凸顯。諸如「Tegaderm™ CHG」之類的產品,憑藉其傷口保護和抗菌功能的雙重優勢,已成為高級產品。
預計這些產品將繼續在中央靜脈導管護理中發揮重要作用。
預製固定裝置
MCSD(人工固定裝置)旨在減少導管移位和脫落。它們通常與PICC、CVC和中線導管等昂貴導管一起使用。
PIVC的廣泛應用仍然是一個重要的機遇,但受到成本的限制。
無需縫合的固定
無縫線固定方法持續受到關注,因為它們降低了傳統縫合的一些風險,並簡化了導管固定。
這一趨勢正在推動製造的、固定式平台的普及。
補充固定和加固材料
為了提高導管穩定性,使其超越標準敷料和固定系統,人們正在開發輔助固定裝置。
這些產品可望減少導管故障和意外脫落,進而提高病患安全。
脫離式安全機制
這種脫離式安全機制旨在減少導管受力時可能併發症。 Lineus Medical 的這項技術就是一個旨在防止導管意外脫落的創新範例。
未來,這些技術在高風險醫療環境中可能會變得更加重要。
PIVC固定業務機會
周邊靜脈留置針 (PIVC) 佔導管使用量的最大比例,而 PIVC 固定術則代表著巨大的成長機會。
然而,在 PIVC 中採用 MCSD 取決於證明其成本合理性、提供臨床證據,並證明固定可以減少重新插入的需要和整體治療成本。
地區
本報告涵蓋全球範圍,包括北美、歐洲、亞太地區、拉丁美洲以及中東和非洲。
iData Research 的「全球導管固定市場報告」透過設備層面的分析、平均售價 (ASP) 數據、企業市場占有率分析以及到 2032 年的預測來解答這些問題。該報告可用於評估需求、比較競爭對手、了解固定技術創新以及製定全球導管固定市場的產業計畫。
Global Catheter Securement Market Report to 2032
The global catheter securement market was valued at $2.2 billion in 2025. It is expected to grow at a compound annual growth rate (CAGR) of 3.2%, reaching $2.7 billion by 2032.
This report covers the global market for catheter securement, including tape and dressings, manufactured catheter securement devices (MCSDs), and sutures.
The analysis includes unit sales, average selling prices (ASPs), market size, market shares, growth trends, market forecasts through 2032, and historical data back to 2022.
Market growth is supported by the rising number of catheter insertions, broader adoption of premium securement products, and efforts to reduce infection and catheter-related complications. However, high MCSD prices and competitive pressure are expected to limit stronger market value growth.
Market Overview
The global catheter securement market includes products used to stabilize vascular access devices and reduce the risk of catheter movement, dislodgement, infection, and complications.
The market includes tape and dressings, sutures, and manufactured catheter securement devices. These products are used across peripheral and central vascular access settings, including PIVCs, PICCs, CVCs, midlines, and other catheter types.
Catheter securement is closely tied to the volume of catheter insertions. Since a large share of hospital inpatients receive IV access, securement products are used at high volume across healthcare settings.
Adjunct technologies designed to improve securement effectiveness are supporting incremental market expansion. Adhesive-based securement enhancers and breakaway safety mechanisms illustrate innovation beyond traditional securement platforms. These technologies aim to reduce catheter failure, improve patient safety, and strengthen the value proposition of securement systems across both central and peripheral access settings.
Market Drivers
Increase in the Number of Catheters Inserted
The number of catheters inserted is a major driver of the catheter securement market. Unit sales are closely related to the volume of catheter placements across hospital and alternate care settings.
It is estimated that approximately 90% of all hospital inpatients receive an IV. This makes catheter securement a high-use product category because each catheter placement requires some method of stabilization.
As the world population ages, the number of patients requiring hospitalization, infusion therapy, vascular access, and chronic treatment is expected to increase. This will drive growth in the unit sales of catheter securement products over the forecast period.
Motivation to Reduce Infection and Catheter Complications
The motivation to reduce infection and catheter-related complications is another important driver. Reimbursement changes to Medicare, the Institute for Healthcare Improvement Central Line Bundle guidelines, the Infusion Nurses Society's Standards of Practice, and hospital-led safety initiatives have encouraged adoption of premium products.
These initiatives have resulted in more infection-reducing and complication-reducing products entering the market. Examples include antimicrobial dressings and manufactured catheter securement devices designed to improve catheter stability.
The 5 Million Lives Campaign and PIV 5 Rights also support improved securement for catheter insertion. As healthcare systems continue focusing on infection prevention and complication reduction, the market is expected to benefit from continued adoption of higher-priced securement products.
Adjunct Securement Innovation
Adjunct securement technologies are supporting incremental market growth. These products are designed to enhance securement effectiveness, reduce accidental dislodgement, and improve catheter stabilization.
Examples include adhesive-based securement enhancers from Adhezion Biomedical and breakaway safety mechanisms developed by Lineus Medical. These products reflect ongoing innovation beyond traditional dressings, tape, sutures, and standard MCSDs.
The goal of these technologies is to reduce catheter failure and improve patient safety. As hospitals place more emphasis on vascular access management, these adjunct solutions may become more important across both central and peripheral access settings.
Market Limiters
Relatively High Prices for MCSDs
The relatively high ASP of manufactured catheter securement devices is a major limiter. While MCSD growth is evident, their cost limits wider adoption.
These products are more commonly used with expensive central line catheters, but they are not used as often with PIVCs. Since PIVCs represent the vast majority of catheters placed, MCSDs must further penetrate the PIVC market to drive stronger growth.
It can be difficult to justify a securement device that costs more than double the catheter itself. For broader adoption, prices may need to decline, or detailed cost analysis must show that these products reduce complications, restarts, and total care costs enough to justify the investment.
Competitive Pressures for MCSDs
Competitive pressure in the MCSD market is expected to limit value growth. As more companies enter the segment, leading competitors will attempt to defend market share.
This will likely result in ASP erosion over time. The pressure is especially important for MCSDs used with PIVCs, where securement products are less likely to be bundled in kits compared with PICCs or midlines.
Because PIVC securement devices are often selected separately, healthcare providers can choose the product that works best for them instead of using the device packaged with a catheter. This flexibility can increase competition and place pressure on prices.
Pricing Pressure in Mature Dressing Categories
Tape and dressing products represent a large portion of catheter securement demand, but these categories are mature and highly competitive.
Standard dressings and tapes are widely used, and many healthcare providers are sensitive to price due to the high volume of catheter placements. Even premium antimicrobial dressings must justify their added cost through infection-reduction value.
As procurement teams continue to focus on cost control, pricing pressure in mature dressing categories may limit market value growth. Manufacturers must rely on clinical differentiation, antimicrobial features, and ease-of-use improvements to defend pricing.
Market Coverage and Data Scope
Markets Covered and Segmentation
Tape and dressing products are widely used for catheter stabilization and site protection. This category includes standard dressings, IV securement dressings, antimicrobial dressings, and related adhesive products used across central and peripheral access.
Sutures are used to secure certain catheter types, particularly central access devices. While sutures are established and familiar, the market has been affected by the growth of manufactured securement options that avoid some suture-related drawbacks.
Manufactured catheter securement devices are designed to stabilize catheters without relying only on tape, dressing, or sutures. These devices can reduce catheter movement, dislodgement, and related complications, but their higher price can limit adoption, especially in PIVC use.
Each segment is analyzed by market size, market shares, market forecasts, market growth rates, units sold, and average selling prices.
This segmentation helps manufacturers, investors, and strategy teams understand how securement method, catheter type, pricing, infection prevention, and complication reduction are shaping the global catheter securement market.
Competitive Analysis
In 2025, Solventum emerged as the leading company in catheter securement following its spin-off from 3M in April 2024. The company held the dominant share of the dressing market, especially through its Tegaderm(TM) line.
Products such as Tegaderm(TM) CHG antimicrobial dressing strengthen Solventum's market position, although they are sold at a premium. The company also offers Medipore(TM) dressings, which are widely used for IV securement and wound care.
Solventum also has a presence in manufactured securement devices through its PICC/CVC Securement Device + Tegaderm series. This gives the company a modest but notable share of the MCSD market in addition to its leading dressing position.
Becton Dickinson stood out as the major competitor in the manufactured catheter securement market. Its StatLock(R) line, acquired in 2006, remains the dominant MCSD product family.
BD's strong position in PICC, chronic CVC, and midline catheter markets has enabled it to dominate manufactured securement both independently and within catheter kits. However, competition and hesitance from some competitors to purchase directly from BD have led to some share erosion.
Smith & Nephew held a significant share in the dressings market. Its IV3000(R) dressings are used for IV site care and are available in multiple sizes for peripheral and central line securement. The company also offers IV3000(R) 1-Hand Delivery for easier application and HYPAFIX(R) tape for PIVC securement.
Technology and Practice Trends
Antimicrobial Dressings
Antimicrobial dressings are gaining importance as hospitals focus on infection prevention. Products such as Tegaderm(TM) CHG support premium positioning by combining site protection with antimicrobial functionality.
These products are expected to remain important in central line care.
Manufactured Securement Devices
MCSDs are designed to reduce catheter movement and dislodgement. They are more common with higher-cost catheters such as PICCs, CVCs, and midlines.
Greater PIVC penetration remains a key opportunity but is limited by cost.
Sutureless Securement
Sutureless securement continues to gain attention because it can reduce some risks associated with traditional sutures and simplify catheter stabilization.
This trend supports adoption of manufactured securement platforms.
Adjunct Securement Enhancers
Adjunct securement enhancers are emerging to improve catheter stability beyond standard dressing or securement systems.
These products may reduce catheter failure and accidental dislodgement, supporting better patient safety.
Breakaway Safety Mechanisms
Breakaway safety mechanisms are designed to reduce complications when force is applied to a catheter line. Lineus Medical's technology is an example of innovation aimed at preventing accidental line dislodgement.
These technologies may become more relevant in high-risk care settings.
PIVC Securement Opportunity
PIVCs represent the largest catheter volume base, making PIVC securement an important growth opportunity.
However, MCSD adoption in PIVCs depends on cost justification, clinical evidence, and proof that securement reduces restarts and total care costs.
Geography
This report provides global coverage across North America, Europe, Asia-Pacific, Latin America, the Middle East, and Africa.
The Global Catheter Securement Market Report from iData Research answers these questions with device-level analysis, ASP data, company share insights, and forecasts through 2032. Use it to evaluate demand, benchmark competitors, understand securement innovation, and support commercial planning in the global catheter securement market.